Here’s why the director of Hopkins’ Office of Critical Event Preparedness is preparing—but not panicking—amid the COVID-19 global pandemic.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Why the director of Hopkins’ Office of Critical Event Preparedness is preparing but not panicking: Dr. Gabor Kelen, Director of the Johns Hopkins Office of Critical Event Preparedness and Response (CEPAR) talks to Dr. Josh Sharfstein about what’s contributing to public fears about COVID-19, how the institution assesses what actions to take, and his one piece of advice for people experiencing mild symptoms.
Published March 10, 2020
Why the director of Hopkins’ Office of Critical Event Preparedness is preparing but not panicking: Dr. Gabor Kelen, Director of the Johns Hopkins Office of Critical Event Preparedness and Response (CEPAR) talks to Dr. Josh Sharfstein about what’s contributing to public fears about COVID-19, how the institution assesses what actions to take, and his one piece of advice for people experiencing mild symptoms.
Published March 10, 2020
Phase 3 study results of plozasiran in patients with FCS
Evolutions in Duchenne Muscular Dystrophy: Treatment Implications for the Present and Future
IgG4-RD Case Conversations: Retroperitoneal Fibrosis with Refractory Ureteral Involvement
HF Management for Patients with Comorbid Conditions
Level Up Your Skills: Tailoring Management of HF
Analysis of Patients With and Without AF Living With HFmrEF/HFpEF: FINEARTS-HF
Effect of Finerenone on NT-proBNP in HFmrEF/HFpEF: FINEARTS-HF Trial
Kidney Risk Stratification in Finerenone Treatment: FINEARTS-HF Trial
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?
Stay current with the best on medical education
